Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer.
AuteursTolaney SM, de Azambuja E, Kalinsky K, Loi S, Kim SB, Yam C, Rapoport B, Im SA, Pistilli B, Mchayleh W, Cescon DW, Watanabe J, Bañuelas MAL, Freitas-Junior R, Salvador Bofill J, Afshari M, Gary D, Wang L, Lai C, Schmid P
Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized Trial.
AuteursZilli T, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Everaerts W, Shelan M, Conde-Moreno A, Campos FL, Papachristofilou A, Guckenberger M, Scorsetti M, Zapatero A, Iturre AV, Eito C, Couñago F, Muto P, Duthoy W, Mach N, Fonteyne V, Moon D, Thon K, Mercier C, Achard V, Stellamans K, Goetghebeur E, Reynders D, Ost P
The dual gap ionization chamber: a novel ionization chamber design for reference dosimetry to automatically correct for recombination losses in emerging radiotherapy modalities.
AuteursOrts M, Rossomme S, Souris K, de Beco V, Haas T, Durny N, Houyoux GG, Penninckx S, Verpoest L, Vanreusel V, Montay-Gruel PG, Kuess P, Palmans H, Sterpin E
Immuno-radiotherapy enhances tumor control and induces abscopal responses in a humanized mouse model.
AuteursCogels MM, Serra M, Duvillier H, Garaud S, Verset L, Venet D, Iliadi C, de Bakker T, Buisseret L, Rouas R, Sotiriou C, Rothé F, de Caluwé A, Van Gestel D, Penninckx S
Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy.
AuteursBouchart C, Azurmendi Senar O, Navez J, Verset L, Boisson A, Hein M, Stosic K, Quertinmont E, Tafciu V, Zhao S, Mas L, D'Haene N, Van Gestel D, Moretti L, Michiels E, Rooman I, Detours V, Bachet JB, Demetter P, Willard-Gallo K, Nicolle R, Arsenijevic T, Van Laethem JL
